Given that loss of PTEN occurs in approximately 20% of localized and over 60% of advanced/metastatic PCa in patients, it is also of paramount importance to explore in the future whether PTEN loss could serve as a molecular determinant for irradiation-induced downregulation of EZH2 protein and the associated therapeutic benefits in PCa patients. Here, EZH2 is linked to posterior cortical atrophy.